Xeris Biopharma Holdings, Inc. (XERS) insider trading

By person

19 insiders · 68 transactions

39.9×

John Shannon holds 39.9 times base salary in stock. $29.66M of shares against $742.33K in salary for 2025.

Salary from the company's own proxy. The shares are what John Shannon last reported holding, valued at $10.23, the price Common Stock was last bought or sold at on the open market here, on 2 Nov 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Beth Hecht

See Remarks

—

$1.94M (15) scheduled

−$1.94M

1,086,130

0.5957%

$11.11M

+2,808%

John Johnson

Director

—

$1.85M (3)

−$1.85M

707,276

0.3879%

$7.24M

—

Kevin McCulloch

See Remarks

$109.48K (1)

$1.63M (7) scheduled

−$1.53M

1,609,208

0.8826%

$16.47M

+8.0%

Paul R Edick

See Remarks

$654.60K (5)

—

+$654.60K

3,821,494

2.10%

$39.10M

—

Steven Pieper

See Remarks

$104.52K (2)

$566.39K (6) scheduled

−$461.87K

1,346,053

0.7383%

$13.77M

+7,413%

Dawn Halkuff

Director

$9.95K (1)

$431.11K (2)

−$421.16K

124,603

0.0683%

$1.28M

—

Jeffrey W Sherman

Director

$10.10K (1)

$334.52K (1) scheduled

−$324.42K

224,588

0.1232%

$2.30M

—

Barbara-Jean Anne Bormann-Kennedy

Director

—

$203.92K (2) scheduled

−$203.92K

150,693

0.0827%

$1.54M

—

Marla Persky

Director

$10.06K (1)

$211.04K (2) scheduled

−$200.99K

157,063

0.0861%

$1.61M

—

John Patrick Shannon Jr

See Remarks

$259.90K (3)

$349.66K (2) scheduled

−$89.76K

2,898,933

1.59%

$29.66M

+8,892%

James Aloysius Brady

Director

—

$60.04K (1) scheduled

−$60.04K

113,359

0.0622%

$1.16M

—

John P. Schmid

Director

$50.13K (5)

—

+$50.13K

138,359

0.0759%

$1.42M

—

Steven Prestrelski

Chief Scientific Officer

—

$27.16K (1) scheduled

−$27.16K

719,780

0.3948%

$7.37M

—

Anh Tu Nguyen

See Remarks

—

395,023

0.2167%

$4.04M

+30.4%

Kenneth Erland Johnson

See Remarks

—

320,446

0.1758%

$3.28M

+3,278%

Garheng Kong

Director

—

238,337

0.1307%

$2.44M

—

Ricki Louise Fairley

Director

—

135,000

0.0740%

$1.38M

—

Nerissa Kreher

Director

—

33,582

0.0184%

$343.63K

—

Menassie Taddese

Director

—

22,365

0.0123%

$228.85K

—

Xeris Biopharma Holdings, Inc.

What the insiders did Net selling

By person